Haematology

  1. Oxbryta (voxelotor)
    Oxbryta (voxelotor)
    by Global Blood Therapeutics, Inc.
    for Sickle Cell Disease
    €0.00
  2. Inrebic (fedratinib)
    Inrebic (fedratinib)
    by Impact Biomedicines, Inc.
    for Myelofibrosis
    €0.00
  3. Cablivi (caplacizumab)
    Cablivi (caplacizumab)
    by Ablynx NV
    for Acquired thrombotic thrombocytopenic purpura (aTTP)
    €6,792.00
View as Grid List

3 Items

per page
Set Descending Direction